title: Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
authors: Hongyan
authors: H
authors: Tong
authors: Kongfei
authors: K
authors: Li
authors: Chen
authors: C
authors: Mei
authors: Huanping
authors: H
authors: Wang
authors: Zhimei
authors: Z
authors: Chen
authors: Jie
authors: J
authors: Jin
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D008875:Middle Aged; D010087:Oxides / Q000627:therapeutic use*; D011379:Prognosis; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D011993:Recombinant Fusion Proteins; D014212:Tretinoin; D000077237:Arsenic Trioxide